Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1975 Mar;2:425–434.

Prognostic significance of primary site after radiotherapy in non-Hodgkin's lymphomata.

K Musshoff, H Schmidt-Vollmer
PMCID: PMC2149601  PMID: 1101929

Abstract

In contrast to Hodgkin's lymphomata, non-Hodgkin's lymphomata originate in approximately a fourth of the cases in extranodal organs and sites. The prognosis of patients with primary extranodal organ involvement of the non-Hodgkin's lymphomata is similar to that of patients with primary lumph node involvement of the Hodgkin's and non-Hodgkin's lymphomata, dependent on the special spreading of the disease corresponding to the 4 stages of the Ann Arbor classification. This applies to the primary involvement of a single lymph node region (Stage I) or a single extralymphatic organ or site (stage IE) as well as to further stages of spreading within the lymphatic system (Stages II and III) including secondary localized involvement of an extralymphatic organ and site (Stages IIE and IIIE). The same qualitative dependence of the prognosis of Hodgkin's and non-Hodgkin's lymphomata on the spatial spreading, corresponding to the Ann Arbor concept, legitimizes, in spite of some quantitative differences, the application of the Ann Arbor classification system to all malignant lymphomata.

Full text

PDF
425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown T. C., Peters M. V., Bergsagel D. E., Reid J. A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Br J Cancer Suppl. 1975 Mar;2:174–186. [PMC free article] [PubMed] [Google Scholar]
  2. Brugère, Schlienger M., Gérard-Marchant R., Tubiana M., Pouillart P., Cachin Y. Non-Hodgkin's malignant lymphomata of upper digestive and respiratory tract: natural history and results of radiotherapy. Br J Cancer Suppl. 1975 Mar;2:435–440. [PMC free article] [PubMed] [Google Scholar]
  3. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  4. Chaffey J. T., Rosenthal D. S., Pinkus F., Hellman S. Advanced lymphosarcoma treated by total body irradiation. Br J Cancer Suppl. 1975 Mar;2:441–449. [PMC free article] [PubMed] [Google Scholar]
  5. Dorfman R. F. Relationship of histology to site in Hodgkin's disease. Cancer Res. 1971 Nov;31(11):1786–1793. [PubMed] [Google Scholar]
  6. Glatstein E., Guernsey J. M., Rosenberg S. A., Kaplan H. S. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer. 1969 Oct;24(4):709–718. doi: 10.1002/1097-0142(196910)24:4<709::aid-cncr2820240408>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  7. HICKS E. B., RAPPAPORT H., WINTER W. J. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul-Aug;9(4):792–821. doi: 10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Johnson R. E., DeVita V. T., Kun L. E., Chabner B. R., Chretien P. B., Berard C. W., Johnson S. K. Patterns of involvement with malignant lymphoma and implications for treatment decision making. Br J Cancer Suppl. 1975 Mar;2:237–241. [PMC free article] [PubMed] [Google Scholar]
  9. Johnson R. E. Management of generalized malignant lymphomata with "systemic" radiotherapy. Br J Cancer Suppl. 1975 Mar;2:450–455. [PMC free article] [PubMed] [Google Scholar]
  10. LUKES R. J. RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGES IN HODGKIN'S DISEASE. Am J Roentgenol Radium Ther Nucl Med. 1963 Nov;90:944–955. [PubMed] [Google Scholar]
  11. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  12. Moran E. M., Ultmann J. E., Ferguson D. J., Hoffer P. B., Ranniger K., Rappaport H. Staging laparotomy in non-Hodgkin's lymphoma. Br J Cancer Suppl. 1975 Mar;2:228–236. [PMC free article] [PubMed] [Google Scholar]
  13. Musshoff K. Prognostic and therapeutic implications of staging in extranodal Hodgkin's disease. Cancer Res. 1971 Nov;31(11):1814–1827. [PubMed] [Google Scholar]
  14. Musshoff K., Schmidt-Vollmer H., Merten D. Reticulum cell sarcoma, an oncologic model for a system of classifying the malignant lymphomas. Eur J Cancer. 1971 Oct;7(5):451–457. doi: 10.1016/0014-2964(71)90043-0. [DOI] [PubMed] [Google Scholar]
  15. Peckham M. J., Guay J. P., Hamlin I. M., Lukes R. J. Survival in localized nodal and extranodal non-Hodgkin's lymphomata. Br J Cancer Suppl. 1975 Mar;2:413–424. [PMC free article] [PubMed] [Google Scholar]
  16. Peters M. V., Bush R. S., Brown T. C., Reid J. The place of radiotherapy in the control of non-Hodgkin's lymphomata. Br J Cancer Suppl. 1975 Mar;2:386–401. [PMC free article] [PubMed] [Google Scholar]
  17. Rosenberg S. A. A critique of the value of laparotomy and splenectomy in the evaluation of patients with Hodgkin's disease. Cancer Res. 1971 Nov;31(11):1737–1740. [PubMed] [Google Scholar]
  18. Rosenberg S. A., Dorfman R. F., Kaplan H. S. A summary of the results of a review of 405 patients with non-Hodgkin's lymphoma at Stanford University. Br J Cancer Suppl. 1975 Mar;2:168–173. [PMC free article] [PubMed] [Google Scholar]
  19. Tubiana M., Pouillart P., Hayat M., Schlienger M., Gérard-Marchant R., Schlumberger J., Brugere J., Amiel J-L, Mathé G. Results of radiotherapy in stages I and II of non-Hodgkin's lymphoma. Br J Cancer Suppl. 1975 Mar;2:402–412. [PMC free article] [PubMed] [Google Scholar]
  20. Van Unnik J. A., Breur K., Burgers J. M., Cleton F., Hart A. A., Kroese W. F., Somers R., Van Turnhout J. M. Non-Hodgkin's lymphomata: clinical features in relation to histology. Br J Cancer Suppl. 1975 Mar;2:201–207. [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES